In summary, prior to advanced 5T33 myeloma burden, there are splenic PD-1+ T cells that appeared to be chronically activated, as demonstrated by expression of activation markers CD69, OX-40 and CD103, and inhibitory receptors LAG-3 and TIM-3. Here, HAVCR2 is linked to plasma cell myeloma.